Form D · Pharmaceuticals
PIERIS PHARMACEUTICALS, INC.
Boston, MA · CIK 0001583648
Offering snapshot reported Nov 20, 2019 · SEC filing
- Reported sold
- $32M Offering amount: $32M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 6, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 20, 2019 | Initial | $32,003,108 | No comparison | 9 | SEC filing |
| Jun 15, 2016 | Initial | $16,500,440 | No comparison | 15 | SEC filing |
| Dec 31, 2014 | Initial | $40,000,000 | No comparison | 21 | SEC filing |
| Dec 31, 2014 | Initial | $13,559,020 | No comparison | 139 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $796K
- Finders' fees
- $0
- Form D file number
- 021-353790
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| William Blair & Company | 1252 |
Source: Form D, filed Nov 20, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ann Barbier, M.D., Ph.D. | Director |
| Jean Pierre Bizzari | Director |
| Jean Pierre Bizzari, M.D. | Director |
| Tom Bures | Executive |
| Darlene Deptula Hicks | Executive |
| James Geraghty | Director |
| Hitto Kaufmann, Ph.D. | Executive |
| Chau Khuong | Director |
| Peter Kiener, D.Phil. | Director |
| Christopher Kiritsy | Director |
| Ahmed Mousa | Executive |
| Steven Prelack | Director |
| Michael Richman | Director |
| Maya R. Said, Sc.D. | Director |
| Matthew L. Sherman, M.D. | Director |
| Christina Takke | Director |
| Stephen S. Yoder | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
255 State Street 9 Th Floor
Boston, MA, 02109
Boston, MA, 02109